[1] van Vollenhoven R F, Severens J L. Observational studies: a valuable source for data on the true value of RA therapies[J]. Clin Rheumatol, 2011, 30 (1):S19-S24.
[2] Karkucak M, Capkin E, Ozsu S, et al.An evaluation ofthe tuberculin skin test for anti TNF alpha prophylaxis in patients with ankylosing spondylitis and rheumatoid arthritis [J]. Bratisl Lek Listy, 2010, 111(9):498-501.
[3] Shirinski I V, Zheltova O I, Shirinski V S, et al.Relationship between blood lipid spectrum and activity ofthe disease in patients with rheumatoid arthritis[J]. Klin Med (Mosk), 2008,86(12):40-43.
[4] Kiely P, Walsh D, Williams R,et al.Outcome in rheumatoid arthritis patients with continued conventional therapy for moderate disease activity-theearly RA network (ERAN)[J].Rheumatology(Oxford), 2011,50(5):926-931.
[5] 张敏波. RA患者血清IL-6、TNF-α CCP检测的临床意义[J]. 放射免疫学杂志,2012,25(2):150.
[6] 罗心静,莫选荣,周玲玲. TNF-α诱导类风湿关节炎滑膜细胞NF-κB信号通路活化的探讨[J]. 免疫学杂志,2012,28(4):321-323.
[7] Pease C, Pope J E, Truong D, et al. Comparison of anti-TNF treatment initiation in rheumatoid arthritis databases demonstrates wide countryvariability in patient parameters at initiation of anti-TNF therapy[J]. Semin Arthritis Rheum,2011,41(1):81-99.
[8] Efremova S N, Dovgaliuk I F, Sakharova IIa. Immunological parameters in the assessment of the activity of specific process in Mycobacterium tuberculosis-infected children and patients with intrathoracic lymphatic tuberculosis[J]. Probl Tuberk Bolezn Legk, 2009,(1):48-51.
[9] Blaschke S, Viereck V, Schwarz G,et al.Anti-inflammatory effects of atorvastatin on peripheral blood mononuclear cells and synovial fibroblasts inrheumatoid arthritis[J].Scand J Rheumatol, 2009,38(4):235-239.
[10]Schuster F L, Yagi S, Gavali S, et al. Under the radar: balamuthia amebic encephalitis[J]. Clin Infect Dis, 2009,48(7):879-887.
[11] 张北,王聪华,王彦宏,等. CyPA对类风湿关节炎中性粒细胞的趋化和产生IL-8的作用及其意义[J]. 细胞与分子免疫学杂志,2009, 25(5):423-425.
